‘The time for experimenting on patients is over’: a policy scan and qualitative study of doctors’ experience with the oversight of clinical innovation in Australia

States and territories have developed fragmented, duplicative and sometimes opaque oversight mechanisms, creating unnecessary complexity and potential gaps in coordination. To improve the oversight of clinical innovation in Australia, a national framework is required that establishes clear processes for the introduction of innovative interventions while permitting jurisdictional modifications in local contexts.